Access to this 750 mcg Teriparatide formulation within Australia is currently . Despite it is listed for use to treat osteoporosis, availability of this higher dose product are significantly restricted . Doctors might need to apply specific approval from the appropriate pathway gain it for patient's patients . It's crucial consideration that region